AI-driven chart review accurately identifies potential rare disease trial participants
Medical Xpress
March 3, 2026
New research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) to identify patients who are eligible for a rare disease clinical trial. Published in The Journal of Cardiac Failure, the study offers real-world evidence that artificial intelligence (AI)-enabled medical chart review can improve the speed, accuracy, and equity of trial enrollment.
Verticals
healthmedical
Originally published on Medical Xpress on 3/3/2026